FDA Drug Application (085461) for LIBRIUM by VALEANT PHARM INTL

Back to FDA Applications sponsored by VALEANT PHARM INTL

Application Number085461
Product Number001
FormCAPSULE;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLIBRIUM
Active IngredientCHLORDIAZEPOXIDE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CHLORDIAZEPOXIDE HYDROCHLORIDE6


Back to FDA Applications sponsored by VALEANT PHARM INTL